India Will Examine Single-Dose Sputnik Light Covid Vaccine Data: Niti Aayog

NITI Aayog member VK Paul said they will go through the data and immunogenicity of of Russia's Sputnik Light Covid vaccine, and after that will decide on its use.

India will examine the claim that a single dose of Russian vaccine "Sputnik Light" can provide protection from the novel coronavirus infection, NITI Aayog member VK Paul said today. "Sputnik V is a two-dose vaccine taken at a gap of three weeks. The unique feature of it is that the antigens in the first and second dose are different from each other. In other vaccines, both doses are the same. In case of Sputnik Light, they (developers) are saying that the first dose is enough. We are examining this claim. We will go through its data and immunogenicity, and after that we will see. Let more information come in," Mr Paul said. He was responding to a query if Sputnik Light will be used in India for vaccinating its population against the infection. Mr Paul noted that if the claims of the vaccine developer are true, it can help double the speed of vaccination in India.